Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer
Costa, Rubens Barros, Costa, Ricardo L B, Talamantes, Sarah M, Kaplan, Jason B, Bhave, Manali A, Rademaker, Alfred, Miller, Corinne, Carneiro, Benedito A, Mahalingam, Devalingam, Chae, Young Kwang
Published in Oncotarget (24.04.2018)
Published in Oncotarget (24.04.2018)
Get full text
Journal Article
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center
Aldrich, Jeffrey, Ekpo, Princess, Rupji, Manali, Switchenko, Jeffrey M., Torres, Mylin A., Kalinsky, Kevin, Bhave, Manali A.
Published in Clinical breast cancer (01.01.2023)
Published in Clinical breast cancer (01.01.2023)
Get full text
Journal Article
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Bhave, Manali A., Quintanilha, Julia C. F., Tukachinsky, Hanna, Li, Gerald, Scott, Takara, Ross, Jeffrey S., Pasquina, Lincoln, Huang, Richard S. P., McArthur, Heather, Levy, Mia A., Graf, Ryon P., Kalinsky, Kevin
Published in Breast cancer research and treatment (01.10.2024)
Published in Breast cancer research and treatment (01.10.2024)
Get full text
Journal Article
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Bhave, Manali A., Quintanilha, Julia C. F., Tukachinsky, Hanna, Li, Gerald, Scott, Takara, Ross, Jeffrey S., Pasquina, Lincoln, Huang, Richard S. P., McArthur, Heather, Levy, Mia A., Graf, Ryon P., Kalinsky, Kevin
Published in Breast cancer research and treatment (01.10.2024)
Published in Breast cancer research and treatment (01.10.2024)
Get full text
Journal Article
Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORx
Lee, Rachel M., Switchenko, Jeffrey M., Ho, Tran B., Arciero, Cletus A., Bhave, Manali A., Subhedar, Preeti D.
Published in Annals of surgical oncology (01.10.2019)
Published in Annals of surgical oncology (01.10.2019)
Get full text
Journal Article
Real-world outcomes of Black women versus non-Hispanic White women with advanced triple-negative breast cancer treated with immune checkpoint inhibitors at an urban cancer center
Aldrich, Jeffrey, Switchenko, Jeffrey M., Kalinsky, Kevin, Bhave, Manali A.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase 1 dose-escalation and expansion-cohort study of the oral CDK7 inhibitor XL102 as a single-agent and in combination therapy in patients (pts) with advanced solid tumors
Shapiro, Geoffrey, Barve, Minal A., Bhave, Manali A., Subbiah, Vivek, Uttamsingh, Shailaja, Sharma, Keerti, Andrianova, Lana, Patnaik, Amita
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Datopotamab deruxtecan in locally advanced/metastatic urothelial cancer: Preliminary results from the phase 1 TROPION-PanTumor01 study
Lisberg, Aaron, Drakaki, Alexandra, Meric-Bernstam, Funda, Alhalabi, Omar, Kojima, Takahiro, Kato, Manabu, Spira, Alexander I., Salkeni, Mohamad Adham, Heist, Rebecca, Gao, Xin, Bhave, Manali A., Klauss, Gunnar, Sakaki, Hayato, Kakurai, Yasuyuki, KOGAWA, TAKAHIRO
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Phase II study of a PARP inhibitor in somatic BRCA1/2 mutant metastatic breast cancer (MBC)
Vidula, Neelima, Damodaran, Senthil, Bhave, Manali A., Rugo, Hope S., Blouch, Erica, Ruffle-Deignan, Nathan Royce, Shah, Ami N., Cristofanilli, Massimo, Abramson, Vandana G, Sparano, Joseph A., Ostrer, Harry, Horick, Nora K., Bardia, Aditya
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Outcomes for black versus white women with stage IV breast cancer enrolled on investigator-initiated clinical trials at Emory
Ekpo, Princess, Torres, Mylin Ann, Rupji, Manali, Switchenko, Jeffrey M., Subhedar, Preeti, Gogineni, Keerthi, Bhave, Manali A.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC)
Bagegni, Nusayba Ali, Nehring, Leslie, Anderson, Jill, Haas, Brittney, Luo, Jingqin, Trivedi, Meghna S., Kennedy, Laura Carpin, Bhave, Manali A., Daily, Karen Colleen, Razaq, Wajeeha, Lu, Yiling, Wang, Wei-Lien, Wulf, Gerburg M., Said, Rabih, Ma, Cynthia X.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors
Falchook, Gerald Steven, Liang, Yan, Harvey, R. Donald, Fu, Siqing, Weitao, Yao, Qin, Yan-ru, Zhang, Xiaojing, Henry, Jason Timothy, Zou, Qingping, Shan, Boyao, Liang, Pan, Wang, Chen, Li, Wenjia, Pamuklar, Zehra Nurgul, Pei, Yi, Chang, Zhiwei, Wang, Jiaqiang, Piha-Paul, Sarina A., Bhave, Manali A., Yin, Yongmei
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Breast cancer patient reported outcomes, depression, and objective measures of breast cosmesis
McManus, Shauna, Lin, Jolinta Y, Bhave, Manali A., Brown, Gabrielle, Green, India, Yang, Xiaofeng, Liu, Tian, Miller, Andrew H., Torres, Mylin Ann
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase 1a/b trial of imlunestrant (LY3484356), an oral selective estrogen receptor degrader (SERD) in ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC): Monotherapy results from EMBER
Jhaveri, Komal L., Jeselsohn, Rinath, Lim, Elgene, Hamilton, Erika P., Yonemori, Kan, Beck, J. Thaddeus, Kaufman, Peter A., Sammons, Sarah, Bhave, Manali A., Saura, Cristina, Calvo, Emiliano, Meniawy, Tarek, Larson, Timothy, Ma, Cynthia X., García-Corbacho, Javier, Cao, Shanshan, Estrem, Shawn T., Milata, Jennifer L., Nguyen, Bastien, Beeram, Muralidhar
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase I/II study of the combination of temozolomide (TM) and pazopanib (PZ) in advanced pancreatic neuroendocrine tumors (PNETs) (NCT01465659)
Bhave, Manali A., Kircher, Sheetal Mehta, Kalyan, Aparna, Berlin, Jordan, Mulcahy, Mary Frances, Cohen, Steven J., Denlinger, Crystal S., Chiorean, E. Gabriela, Sahai, Vaibhav, Zalupski, Mark, Rademaker, Alfred, Benson, Al Bowen, Nimeiri, Halla
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article